COLRF (Tian An Medicare) Risk Assessment

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

COLRF Tian An Medicare Ltd COLRF
43 GF Score
Price $0.08
GF Value $0.07
! 4 Warning Signs
View Full Analysis

What is Tian An Medicare Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Tian An Medicare is: No Data: Cannot be evaluated.

Tian An Medicare  (OTCPK:COLRF) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Tian An Medicare Risk Assessment Related Terms

COLRF vs HCA, THC, DVA: Risk Assessment Comparison

For the Medical Care Facilities subindustry, Tian An Medicare's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tian An Medicare Risk Assessment vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Tian An Medicare's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Tian An Medicare's Risk Assessment falls into.


COLRF
43GF Score
Tian An Medicare Ltd COLRF
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Tian An Medicare (COLRF) Overvalued in 2026?

Based on GuruFocus' analysis, Tian An Medicare stock appears to be overvalued. The current stock price of $0.08 is trading 14.3% above its estimated GF Value™ of $0.07.

Key valuation signals for COLRF:

  • Risk Assessment:
  • GF Value™: $0.07 vs. price of $0.08 (14.3% above fair value)
  • GF Score™: 43/100 with 4 warning signs

No single metric tells the full story. See the COLRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tian An Medicare Business Description

Other Exchanges 00383:Hong KongSMI:Germany
Address No. 138 Gloucester Road, Rooms 1904B-5, 19th Floor, Allied Kajima Building, Wanchai, Hong Kong, HKG
Tian An Medicare Ltd is an investment holding company and operator of integrated healthcare and eldercare services. Its main focus is on the investment, management and operations of healthcare and eldercare businesses, and the related property investment and development, and comprehensive spectrum of healthcare and eldercare services to customers in the People's Republic of China (PRC) and Asia Pacific. The Group is also involved in businesses of securities trading and investment, and provision of financial services. Its segments includes: Healthcare; Eldercare; and Property Development, of which it derives maximum revenue from Healthcare segment.
43GF Score

Get the complete analysis for COLRF

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.08
Price
$0.07
GF Value